https://orcid.org/0000-0001-5833-2428
About the Authors
- Caroline Verhestraeten
-
Roles Conceptualization, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
* E-mail: caroline.verhestraeten@novartis.com
Affiliation Novartis Pharma nv-sa, Vilvoorde, Belgium
- Gijs Weijers
-
Roles Validation, Writing – review & editing
Affiliation Department of Cardiology, Centre Hospitalier Bois de l’Abbaye, Seraing, Belgium
- Daphne Debleu
-
Roles Validation, Writing – original draft, Writing – review & editing
Affiliation Novartis Pharma nv-sa, Vilvoorde, Belgium
- Agnieszka Ciarka
-
Roles Validation, Writing – review & editing
Affiliations Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium, Katholieke Universiteit Leuven, Leuven, Belgium
- Marc Goethals
-
Roles Validation, Writing – review & editing
Affiliation Department of Cardiology, OLV Hospital Aalst, Aalst, Belgium
- Steven Droogmans
-
Roles Validation, Writing – review & editing
Affiliation Department of Cardiology, Centrum Voor Hart-en Vaatziekten, Jette, Belgium
- Michael Maris
-
Roles Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation Novartis Pharma nv-sa, Vilvoorde, Belgium
Competing Interests
The authors have read the journal's policy and have the following Competing Interests to declare: Dr G. Weijers, Dr A. Ciarka, Dr M. Goethals and Dr S. Droogmans received a consultancy fee from Novartis Pharma Belgium for the interpretation of the results, development of the algorithm and review of the manuscript. Michael Maris and Caroline Verhestraeten are employees of Novartis Pharma Belgium. Daphné Debleu was doing an internship during the development of this project at Novartis Pharma Belgium. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.